相关实验视频

Updated: May 26, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

化学抗原受体细胞疗法:强化固体瘤的治疗策略

Tang-Her Jaing¹, Yi-Wen Hsiao², Yi-Lun Wang¹

¹Division of Hematology and Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, 5 Fu-Shin Street, Kwei-Shan, Taoyuan 33315, Taiwan.

Current issues in molecular biology

|February 25, 2025

概括

化学抗原受体 (CAR) 细胞疗法在固体瘤中显示出前景. 新的CAR-NK,CAR-iNKT和CAR-M细胞可能会克服限制CAR-T细胞有效性的挑战.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
细胞疗法细胞疗法

背景情况:

化学抗原受体-T (CAR-T) 细胞疗法对血液癌症有效,但在固体瘤中有限.
固体瘤带来了诸如敌对的微环境,瘤异质性以及CAR-T细胞透和持久性差等挑战.
在固体瘤中CAR-T细胞无效的确切原因需要进一步阐明.

研究的目的:

审查目前的CAR细胞治疗固体瘤的现状.
为了突出新兴的CAR-NK,CAR-iNKT和CAR-M细胞战略.
讨论这些新型CAR细胞类型在克服固体瘤特异性挑战方面的潜力.

主要方法:

关于对固体瘤进行CAR细胞治疗研究的文献综述.
对专注于CAR-NK,CAR-iNKT和CAR-M细胞发育的研究进行分析.
检查增强瘤微环境中的CAR细胞疗效的策略.

主要成果:

在固体瘤治疗中,CAR-T细胞疗法面临着重大障碍.
新兴的CAR-NK,CAR-iNKT和CAR-M细胞疗法显示出潜力.
特别是CAR-NK细胞,在克服固体瘤微环境障碍,如缺氧等方面表现有前途.

结论:

新型CAR细胞疗法,包括CAR-NK,CAR-iNKT和CAR-M,为固体瘤治疗提供了新的途径.
优化这些CAR细胞类型对于临床转化至关重要.
需要进一步的研究来验证组合方法,并充分了解固体瘤中CAR细胞的行为.

关键词:

仿制性抗原受体的仿制性抗原受体不变的自然杀手T T 巨细胞是一个巨细胞.自然杀手是自然杀手.固体瘤是一个固体瘤.瘤微环境是一个微环境.

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...